Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Amsacrine × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Recurrence 1 Leukemia, Myeloid, Acute 1

Interventions

pembrolizumab 531 Cyclophosphamide 491 Magnetic Resonance Spectroscopy 461 Radiotherapy 443 Specimen Handling 436 Nivolumab 381 Carboplatin 330 Cisplatin 325 Biopsy 264 Blood Specimen Collection 260 Radiosurgery 255 Paclitaxel 249 Dexamethasone 243 Gemcitabine 236 Standard of Care 235 venetoclax 231 Surveys and Questionnaires 228 Drug Therapy 228 fludarabine 225 Bevacizumab 214 Rituximab 188 Oxaliplatin 186 Radiation 179 Ipilimumab 179 Fluorouracil 178 Capecitabine 176 durvalumab 165 atezolizumab 162 Doxorubicin 161 Cytarabine 151

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03765541 2025-04-10

DEXAML-03

University Hospital, Toulouse

Phase 3 Terminated

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡